NeuroSense Therapeutics Ltd. (NRSNW)
NRSNW Stock Price Chart
Explore NeuroSense Therapeutics Ltd. interactive price chart. Choose custom timeframes to analyze NRSNW price movements and trends.
NRSNW Company Profile
Discover essential business fundamentals and corporate details for NeuroSense Therapeutics Ltd. (NRSNW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Dec 2021
Employees
17.00
Website
https://www.neurosense-tx.comCEO
Alon Ben-Noon
Description
NeuroSense Therapeutics Ltd. is an Israeli clinical-stage biotechnology firm dedicated to pioneering novel therapies for severe neurodegenerative conditions. Its most advanced investigational asset is PrimeC, an innovative oral compound specifically engineered to address amyotrophic lateral sclerosis (ALS). Beyond its lead program, the company boasts a preclinical pipeline featuring StabiliC, aimed at Parkinson's disease, and CogniC, targeting Alzheimer's disease. Established in Herzliya, Israel, in 2017, NeuroSense Therapeutics continues to advance its therapeutic initiatives.
NRSNW Financial Timeline
Browse a chronological timeline of NeuroSense Therapeutics Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.20, while revenue estimate is $267.80k.
Earnings released on 22 Jun 2026
Earnings released on 31 Mar 2026
EPS came in at -$0.24 falling short of the estimated -$0.07 by -231.92%.
Earnings released on 26 Nov 2025
EPS came in at -$0.04 surpassing the estimated -$0.04 by +8.47%.
Earnings released on 1 Aug 2025
EPS came in at -$0.14 surpassing the estimated -$0.22 by +38.14%.
Earnings released on 28 May 2025
EPS came in at -$0.11 falling short of the estimated -$0.10 by -4.80%.
NRSNW Stock Performance
Access detailed NRSNW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
